Iman El Hariry, M.D., Ph.D.

Chief Medical Officer

Dr. El-Hariry is an oncologist with more than 15 years of global cancer drug product development experience and extensive familiarity with the international oncology community and regulatory authorities. She is currently Chief Medical Officer at ERYTECH Pharma, and was previously VP of Oncology Clinical Research at Synta Pharmaceuticals, Global Head of Oncology at Astellas Pharma and Group Director of Oncology Clinical Development at GlaxoSmithKline. Over the course of her career, she has successfully led the development and regulatory approvals of multiple products in Europe and the US, including lapatinib and neralabine. Dr. El-Hariry received her M.D. degree from Alexandria University and her Ph.D. from Imperial College London.